Chrousos GP - Search Results

1

Expression of proopiomelanocortin, corticotropin-releasing hormone (CRH), and CRH receptor in melanoma cells, nevus cells, and normal human melanocytes.

Funasaka Y, Sato H, Chakraborty AK, Ohashi A, Chrousos GP, Ichihashi M. Funasaka Y, et al. Among authors: chrousos gp. J Investig Dermatol Symp Proc. 1999 Sep;4(2):105-9. doi: 10.1038/sj.jidsp.5640192. J Investig Dermatol Symp Proc. 1999. PMID: 10536983 Free article.

2

The expression of corticotropin-releasing hormone in melanoma.

Sato H, Nagashima Y, Chrousos GP, Ichihashi M, Funasak Y. Sato H, et al. Among authors: chrousos gp. Pigment Cell Res. 2002 Apr;15(2):98-103. doi: 10.1034/j.1600-0749.2002.1o063.x. Pigment Cell Res. 2002. PMID: 11936276

3

Endometrial and placental CRH as regulators of human embryo implantation.

Makrigiannakis A, Zoumakis E, Kalantaridou S, Chrousos G. Makrigiannakis A, et al. J Reprod Immunol. 2004 Jun;62(1-2):53-9. doi: 10.1016/j.jri.2003.11.006. J Reprod Immunol. 2004. PMID: 15288181 Review.

4

Uterine and embryonic trophoblast CRH promotes implantation and maintenance of early pregnancy.

Makrigiannakis A, Zoumakis E, Kalantaridou S, Chrousos G, Gravanis A. Makrigiannakis A, et al. Ann N Y Acad Sci. 2003 Nov;997:85-92. doi: 10.1196/annals.1290.010. Ann N Y Acad Sci. 2003. PMID: 14644813 Review.

5

Functional characteristics of CRH receptors and potential clinical applications of CRH-receptor antagonists.

Grammatopoulos DK, Chrousos GP. Grammatopoulos DK, et al. Among authors: chrousos gp. Trends Endocrinol Metab. 2002 Dec;13(10):436-44. doi: 10.1016/s1043-2760(02)00670-7. Trends Endocrinol Metab. 2002. PMID: 12431840 Review.

6

Effect of antalarmin, a novel corticotropin-releasing hormone antagonist, on the dynamic function of the preterm ovine fetal hypothalamo-pituitary-adrenal axis.

Young IR, Chan EC, Smith R, Chrousos GP, Veldhuis JD, Canny BJ. Young IR, et al. Among authors: chrousos gp. Neuroendocrinology. 2002 Jul;76(1):47-54. doi: 10.1159/000063683. Neuroendocrinology. 2002. PMID: 12097816

7

Participation of maternal and fetal CRH in early phases of human implantation: the role of antalarmin.

Makrigiannakis A, Zoumakis E, Kalantaridou S, Chrousos G, Gravanis A. Makrigiannakis A, et al. Curr Drug Targets Immune Endocr Metabol Disord. 2004 Mar;4(1):75-8. doi: 10.2174/1568008043339992. Curr Drug Targets Immune Endocr Metabol Disord. 2004. Retraction in: Endocr Metab Immune Disord Drug Targets. 2010 Mar;10(1):83. PMID: 15032629 Retracted. Review.

8

Involvement of the neuropeptide corticotropin-releasing hormone in an animal model of Shigella-related seizures.

Yuhas Y, Weizman A, Chrousos GP, Ovadia H, Ashkenazi S. Yuhas Y, et al. Among authors: chrousos gp. J Neuroimmunol. 2004 Aug;153(1-2):36-9. doi: 10.1016/j.jneuroim.2004.04.009. J Neuroimmunol. 2004. PMID: 15265661

9

Cerebrospinal fluid levels of corticotropin-releasing hormone in women with functional hypothalamic amenorrhea.

Berga SL, Loucks-Daniels TL, Adler LJ, Chrousos GP, Cameron JL, Matthews KA, Marcus MD. Berga SL, et al. Among authors: chrousos gp. Am J Obstet Gynecol. 2000 Apr;182(4):776-81; discussion 781-4. doi: 10.1016/s0002-9378(00)70326-7. Am J Obstet Gynecol. 2000. PMID: 10764453

10

Corticotropin-releasing hormone induces skin mast cell degranulation and increased vascular permeability, a possible explanation for its proinflammatory effects.

Theoharides TC, Singh LK, Boucher W, Pang X, Letourneau R, Webster E, Chrousos G. Theoharides TC, et al. Endocrinology. 1998 Jan;139(1):403-13. doi: 10.1210/endo.139.1.5660. Endocrinology. 1998. PMID: 9421440

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,397 results

Search Page

Filters